Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Withdrawn 4 Terminated 3 Recruiting 3 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 11 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Fallopian Tube Neoplasms 3 Advanced Pancreatic Cancer 3 Esophageal Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Staging IV NSCLC 1 Squamous Cell Carcinoma of Lung 1 Solid Tumor 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Ovarian gynandroblastoma 1 Obesity 1 Neurotoxicity Syndromes 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Liver Neoplasms 1 HER2-negative Breast Cancer 1 HER2+ Breast Cancer 1 Granulosa cell tumor of the ovary 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Taxes × Clear all

NCT04652206 2021-12-29

PANTAX-Ib

Scandion Oncology A/S

Phase 1/2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡